| 1 | our commitment in healthcare | | | | | | | 3 | 0.33% |
| 2 | for indonesia is incontestable | | | | | | | 3 | 0.33% |
| 3 | service for the world | | | | | | | 3 | 0.33% |
| 4 | which are based on | | | | | | | 3 | 0.33% |
| 5 | especially for indonesia is | | | | | | | 3 | 0.33% |
| 6 | products which are based | | | | | | | 3 | 0.33% |
| 7 | 29 2021 patient monitor | | | | | | | 2 | 0.22% |
| 8 | march 29 2021 patient | | | | | | | 2 | 0.22% |
| 9 | is incontestable so we | | | | | | | 2 | 0.22% |
| 10 | commit to develop our | | | | | | | 2 | 0.22% |
| 11 | get to know fillmed | | | | | | | 2 | 0.22% |
| 12 | commitment in healthcare service | | | | | | | 2 | 0.22% |
| 13 | distribution for the products | | | | | | | 2 | 0.22% |
| 14 | indonesia is incontestable so | | | | | | | 2 | 0.22% |
| 15 | stimulator theraset® is a | | | | | | | 2 | 0.22% |
| 16 | collagen stimulator theraset® is | | | | | | | 2 | 0.22% |
| 17 | study with new technology | | | | | | | 2 | 0.22% |
| 18 | scientific study with new | | | | | | | 2 | 0.22% |
| 19 | on scientific study with | | | | | | | 2 | 0.22% |
| 20 | based on scientific study | | | | | | | 2 | 0.22% |
| 21 | for the products which | | | | | | | 2 | 0.22% |
| 22 | about us contact us | | | | | | | 2 | 0.22% |
| 23 | the products which are | | | | | | | 2 | 0.22% |
| 24 | in healthcare service for | | | | | | | 2 | 0.22% |
| 25 | rss contact us follow | | | | | | 2 | 0.22% |
| 26 | healthcare service for the | | | | | | | 2 | 0.22% |
| 27 | on facebook add to | | | | | | | 2 | 0.22% |
| 28 | facebook add to our | | | | | | | 2 | 0.22% |
| 29 | us follow us on | | | | | | | 2 | 0.22% |
| 30 | contact us follow us | | | | | | | 2 | 0.22% |
| 31 | are based on scientific | | | | | | | 2 | 0.22% |
| 32 | add to our circle | | | | | | | 2 | 0.22% |
| 33 | to our circle follow | | | | | | | 2 | 0.22% |
| 34 | our circle follow our | | | | | | | 2 | 0.22% |
| 35 | circle follow our instagram | | | | | | | 2 | 0.22% |
| 36 | our distribution for the | | | | | | | 1 | 0.11% |
| 37 | develop our distribution for | | | | | | | 1 | 0.11% |
| 38 | to develop products which | | | | | | | 1 | 0.11% |
| 39 | products our commitment in | | | | | | | 1 | 0.11% |
| 40 | commit to develop products | | | | | | | 1 | 0.11% |